PIM
GILD icon

Parker Investment Management’s Gilead Sciences GILD Stock Holding History

Parker Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-26,732
Closed -$1.82M – 20
2017
Q1 		$1.82M Sell
26,732
-1,000
-4% -$70.3K 0.94% 11
2016
Q4 		$1.99M Sell
27,732
-50
-0.2% -$3.72K 1.07% 11
2016
Q3 		$2.2M Buy
27,782
+2
+0% +$162 0.78% 19
2016
Q2 		$2.32M Hold
27,780
– – 0.86% 18
2016
Q1 		$2.55M Buy
+27,780
New +$2.51M 0.96% 16

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parker Investment Management's GILD Position: Q2 2017 in Review

Parker Investment Management sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 26,732 shares — an estimated $1.82M sold.

Parker Investment Management first reported a position in GILD in Q1 2016 and held it in 5 quarters. The position peaked at $2.55M in Q1 2016. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Parker Investment Management reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Parker Investment Management sold 26,732 Gilead Sciences shares in Q2 2017, an estimated $1.82M.
  • Parker Investment Management first reported a position in Gilead Sciences in Q1 2016 and held it in 5 quarters.
  • Parker Investment Management's Gilead Sciences position peaked at $2.55M in Q1 2016.
  • 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Parker Investment Management's 13F filing for Q2 2017, filed 14 Jul 2017.